Literature DB >> 30905106

The Incidence and Prevalence of Inflammatory Bowel Disease in the Jewish and Arab Populations of Israel.

Ibrahim Zvidi1, Doron Boltin2, Yaron Niv2, Ram Dickman2, Gerald Fraser2, Shlomo Birkenfeld1.   

Abstract

BACKGROUND: Temporal trends in the incidence of inflammatory bowel disease (IBD) in the Arab and Jewish populations in Israel have been poorly described.
OBJECTIVES: To compare the annual incidence and prevalence rates of Crohn's disease (CD) and ulcerative colitis (UC) in the Arab and Jewish populations in Israel between the years 2003 and 2008.
METHODS: We applied a common case identification algorithm to the Clalit Health Services database to both determine trends in age-adjusted incidence and prevalence rates for IBD in both populations during this period and estimate the burden of IBD in Israel.
RESULTS: The incidence of CD in the Arab population increased from 3.1/100,000 in 2003 to 10.6/100,000 person-years in 2008, compared with a decrease in the Jewish population from 14.3/100,000 to 11.7/100,000 person-years for the same period. The incidence of UC in the Arab population increased from 4.1/100,000 in 2003 to 5.0/100,000 person-years in 2008, a low but stable rate, compared with a decrease from 16.4/100,000 to 9.5/100,000 person-years for the same time period in the Jewish population. The prevalence of both diseases increased due to the accumulation of incident cases but remained much lower among Arabs.
CONCLUSIONS: Understanding the factors underlying the differences in incidence and prevalence of IBD in the Jewish and Arab populations may shed light on the genetic and environmental factors associated with these diseases.

Entities:  

Mesh:

Year:  2019        PMID: 30905106

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  3 in total

1.  Genetic analysis of four consanguineous multiplex families with inflammatory bowel disease.

Authors:  Noam Ben-Yosef; Matthew Frampton; Elena R Schiff; Saleh Daher; Fadi Abu Baker; Rifaat Safadi; Eran Israeli; Anthony W Segal; Adam P Levine
Journal:  Gastroenterol Rep (Oxf)       Date:  2021-07-13

2.  Protein-altering germline mutations implicate novel genes related to lung cancer development.

Authors:  Xuemei Ji; Semanti Mukherjee; Maria Teresa Landi; Yohan Bosse; Philippe Joubert; Dakai Zhu; Ivan Gorlov; Xiangjun Xiao; Younghun Han; Olga Gorlova; Rayjean J Hung; Yonathan Brhane; Robert Carreras-Torres; David C Christiani; Neil Caporaso; Mattias Johansson; Geoffrey Liu; Stig E Bojesen; Loic Le Marchand; Demetrios Albanes; Heike Bickeböller; Melinda C Aldrich; William S Bush; Adonina Tardon; Gad Rennert; Chu Chen; Jinyoung Byun; Konstantin H Dragnev; John K Field; Lambertus Fa Kiemeney; Philip Lazarus; Shan Zienolddiny; Stephen Lam; Matthew B Schabath; Angeline S Andrew; Pier A Bertazzi; Angela C Pesatori; Nancy Diao; Li Su; Lei Song; Ruyang Zhang; Natasha Leighl; Jakob S Johansen; Anders Mellemgaard; Walid Saliba; Christopher Haiman; Lynne Wilkens; Ana Fernandez-Somoano; Guillermo Fernandez-Tardon; Erik H F M van der Heijden; Jin Hee Kim; Michael P A Davies; Michael W Marcus; Hans Brunnström; Jonas Manjer; Olle Melander; David C Muller; Kim Overvad; Antonia Trichopoulou; Rosario Tumino; Gary E Goodman; Angela Cox; Fiona Taylor; Penella Woll; Erich Wichmann; Thomas Muley; Angela Risch; Albert Rosenberger; Kjell Grankvist; Mikael Johansson; Frances Shepherd; Ming-Sound Tsao; Susanne M Arnold; Eric B Haura; Ciprian Bolca; Ivana Holcatova; Vladimir Janout; Milica Kontic; Jolanta Lissowska; Anush Mukeria; Simona Ognjanovic; Tadeusz M Orlowski; Ghislaine Scelo; Beata Swiatkowska; David Zaridze; Per Bakke; Vidar Skaug; Lesley M Butler; Kenneth Offit; Preethi Srinivasan; Chaitanya Bandlamudi; Matthew D Hellmann; David B Solit; Mark E Robson; Charles M Rudin; Zsofia K Stadler; Barry S Taylor; Michael F Berger; Richard Houlston; John McLaughlin; Victoria Stevens; David C Nickle; Ma'en Obeidat; Wim Timens; María Soler Artigas; Sanjay Shete; Hermann Brenner; Stephen Chanock; Paul Brennan; James D McKay; Christopher I Amos
Journal:  Nat Commun       Date:  2020-05-11       Impact factor: 17.694

3.  Bowel Damage at Diagnosis Using the Lémann Index Score in Saudi Arabian Patients With Crohn's Disease.

Authors:  Hajar Halawani; Ahmed Abduljabbar; Mohammad Wazzan; Dalia Abdulmonem Hashem; Cedric Baumann; Amandine Luc; Laurent Peyrin-Biroulet; Omar I Saadah; Mahmoud Mosli
Journal:  Cureus       Date:  2020-10-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.